Advisor Net Financial, Inc Fibrogen Inc Transaction History

Advisor Net Financial, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$0.89 - $2.36 $1,068 - $2,832	-1,200 Reduced 60.0%	800 $0
Q1 2024 Apr 12, 2024	BUY	$0.73 - $2.73 $1,460 - $5,460	2,000 New	2,000 $4,000
Q3 2020 Nov 06, 2020	SELL	$40.47 - $45.5 $248,202 - $279,051	-6,133 Closed	0 $0
Q2 2019 Jul 15, 2019	SELL	$35.13 - $55.53 $7,026 - $11,106	-200 Reduced 3.16%	6,133 $277,000
Q1 2018 May 08, 2018	BUY	$45.35 - $61.65 $9,070 - $12,330	200 Added 3.26%	6,333 $293,000
Q4 2017 Feb 27, 2018	BUY	$41.95 - $60.1 $257,279 - $368,593	6,133	6,133 $291,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Advisor Net Financial, Inc, based on Form 13F filings with the SEC.

Stay updated on Advisor Net Financial, Inc with notifications on news.